Sunday, February 28, 2021

Antipsychotics Increase Risk of Heart Attack in the Elderly

In a study of 10,969 older patients treated with antipsychotics in Quebec, Canada, researchers found a 2.19 times greater risk of heart attack in...

Ongoing Brain Changes With Antipsychotic Treatment

Nancy Andreasen's 2003 study finding ongoing brain changes in persons with schizophrenia diagnoses, despite antipsychotic drug treatment. Article →             ...

Confusion Over Antipsychotic Dosing Data in RAISE Study

Yesterday, the New York Times reported that schizophrenia patients in an experimental treatment program (RAISE) who experienced better outcomes had been on lower doses of antipsychotics than normal. However, the article published in the American Journal of Psychiatry on Tuesday did not divulge any data on the varying antipsychotic drug doses in the different study groups.

Most Preschoolers with ADHD Stay on Meds for Years

About 65% of preschool children who were diagnosed with ADHD and given stimulant drugs were still taking those drugs six years later.

J&J CEO Does Not Have to Testify in Risperdal Gynecomastia Trial

In a victory for Johnson & Johnson, a Philadelphia judge ruled that CEO Alex Gorsky cannot be called as a witness by the plaintiff,...

Information on PRN Medication Practices is Lacking

The authors of an article in Journal of Psychosocial Nursing reviewed the literature on psychotropic PRN medications in order to respond to a request to...

Little Evidence on Effectiveness or Risks of Antipsychotics in Young People

Evidence-Based Mental Health reviews studies (from 1987 to 2011) of antipsychotics in people under 24 years old, finding weak evidence on comparative effectiveness of antipsychotics or...

Nonwhites Twice as Likely to Receive Injectable Antipsychotics

Research published in the Journal of Clinical Psychiatry shows that of all 901 patients diagnosed with schizophrenia from July 2009 to June 2010 at a...

The International Pilot Study of Schizophrenia

The International Pilot Study of Schizophrenia. Leff, J.Psychological Medicine, 22 (1992):131-145. The first World Health Organization study that compared schizophrenia outcomes in "developed" and "developing" countries...
Zyprexa Papers

Big Pharma Meets Big Diagnosis, Big Courts, and Big Psychiatric Hospitals

Gottstein’s book is The Pentagon Papers of the traditional mental health system, because he exposes a mind-blowing number and variety of cold-blooded, calculating actions on the part of Eli Lilly in trying to hide what it knew to be the devastating effects of its hugely profitable Zyprexa.

Still Doing Better Without Antipsychotics?

The Chicago Tribune revisits the issues raised in the 2007 study led by Martin Harrow which found that many people diagnosed with schizophrenia fare...

J&J CEO Avoids Testimony in Philadelphia Risperdal Case

Chief executive Alex Gorsky was once proud enough of Risperdal to put its sales numbers on his resume, according to the Philadelphia Inquirer today,...

FDA Defends Decision to Approve Digital Aripiprazole

Members of the U.S. Food and Drug Administration’s Psychiatry Products division go on the defensive in a new article, responding to concerns about the agency’s approval of digital aripiprazole.

Tapering Neuroleptics: Two Year Results

A colleague and I have been tracking individuals who elect to reduce their dose of neuroleptic drug. The two year results are presented here.

Study Connects Environmental Risk Factors and Psychosis

A meta-analysis of known risk factors for psychosis finds elevated risk with the presence of childhood trauma, adverse life events, and affective dysfunction.

Almost No Nursing Homes Meet Federal Standards for Antipsychotic Use

The Office of the Inspector General finds that 99.5% of nursing facilities in the United States are non-compliant regarding federal regulations concerning antipsychotic use....

Abilify: The Drug That Could Gamble Your Life Away

On this episode of America's Lawyer, Mike Papantonio discusses the numerous lawsuits pending involving the anti-psychotic drug Abilify, which has caused plaintiffs to develop serious...

Paradigm Shift

An important study was headlined on MIA this week. The study examined the effectiveness of cognitive behavioral therapy (CBT) to treat the symptoms of people labeled with a diagnosis of schizophrenia and related conditions who had elected to not take neuroleptic drugs.

“Colorado Responds Slowly to Psychotropic Drug Use Among Foster Kids”

The Denver Post writes "Colorado officials have known since at least 2007 that prescriptions and dosage levels of psychotropic drugs — which also include antidepressants, mood...

England Seeks to Stop Antipsychotics For Dementia

English health minister Paul Burstow is seeking to outlaw the 'silent scandal' of inappropriate antipsychotics for dementia by proposing legislation that imposes up to...

Mental Health Patients Overlooked in Compulsory Treatment

From The Sydney Morning Herald: A new review found that mental health patients' decision-making capacity is very rarely considered in court rulings on involuntary treatment. "The...

Antipsychotics Triple the Risk of Diabetes in Children and Youth

Researchers from Vanderbilt and Columbia Universities and the FDA find that, through a retrospective cohort study of 28,858 patients of the Tennessee Medicaid program...

“Why ARE so Many People Being Labelled Bipolar?”

"For drugs designed for a relatively small number of very disturbed patients, antipsychotics are now among the most profitable drugs in the world, just...

Alarm About Antipsychotics as Sleep Aids

Canadian sleep researchers, writing in The Lancet, warn that weight gain, lipid and glucose dysregulation, restless leg syndrome, sleep-walking and eating while asleep, and...

“No Easy Answer to the Question of Forcible Medication”

Nathaniel Ayers, the violin-playing subject of the 2009 film "The Soloist," continues to fight against efforts to compel him to take antipsychotic medication.  "....

Follow Us

19,639FansLike
11,994FollowersFollow
4,730SubscribersSubscribe